Filing Details

Accession Number:
0001235802-14-000161
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-08 16:20:32
Reporting Period:
2014-12-08
Filing Date:
2014-12-08
Accepted Time:
2014-12-08 16:20:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1372299 Histogenics Corp HSGX Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1435895 Split Rock Partners Ii, Lp 10400 Viking Drive
Suite 250
Eden Prairie MN 55344
No No Yes No
1626028 Split Rock Partners Ii Management, Llc 10400 Viking Drive
Suite 250
Eden Prairie MN 55344
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-08 640,230 $0.00 640,230 No 4 C Direct
Common Stock Acquisiton 2014-12-08 407,825 $0.00 1,048,055 No 4 C Direct
Common Stock Acquisiton 2014-12-08 9,713 $0.76 1,057,768 No 4 X Direct
Common Stock Disposition 2014-12-08 668 $11.00 1,057,100 No 4 S Direct
Common Stock Acquisiton 2014-12-08 333,466 $11.00 1,390,566 No 4 P Direct
Common Stock Disposition 2014-12-08 5,872 $0.00 1,384,694 No 4 J Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 X Direct
No 4 S Direct
No 4 P Direct
No 4 J Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2014-12-08 640,230 $0.00 640,230 $0.00
Common Stock Series A-1 Convertible Preferred Stock Disposition 2014-12-08 407,825 $0.00 407,825 $0.00
Common Stock Common Stock Warrant (Right to Buy) Disposition 2014-12-08 9,713 $0.00 9,713 $0.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 X Direct
Footnotes
  1. Reflects a 10.804-to-1 reverse stock split effected on November 14, 2014.
  2. Each outstanding share of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted on a 1:1 basis into the Issuer's common stock, immediately prior to the closing of the Issuer's initial public offering, for no additional consideration and including accrued dividends. These shares have no expiration date.
  3. The securities are owned directly by Split Rock Partners II, LP ("SRP II"). Voting and investment power over the securities is delegated to Split Rock Partners II Management, LLC ("SRPM II"), the general partner of SRP II. SRPM II has delegated voting and investment decisions to three individuals who require a two-thirds vote to act. SRPM II disclaims beneficial ownership of the securities except to the extent of any pecuniary interest therein.
  4. The Common Stock Warrant was automatically net exercised, immediately prior to the closing of the Issuer's initial public offering. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 668 of the warrant shares to pay the exercise price and issuing the Reporting Person the remaining 9,045 shares. The expiration date of the warrant is upon the consummation of the Issuer's initial public offering or a liquidity event (as described in such warrant).
  5. These shares of Common Stock were transferred to a strategic partner of the Issuer to satisfy the Reporting Person's contractual obligations under certain agreements between the Issuer, the Reporting Person, certain of the Issuer's other stockholders, and such strategic partner.